000			02046 a2200529 4500
005			20250514160313.0
264		0	_c20040614
008			200406s 0 0 eng d
022			_a1567-5769
024	7		_a10.1016/S1567-5769(03)00181-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aSridevi, K
245	0	0	_aReversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. _h[electronic resource]
260			_bInternational immunopharmacology _cNov 2003
300			_a1589-600 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylmuramyl-Alanyl-Isoglutamine _xanalogs & derivatives
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAmmonium Chloride _xpharmacology
650	0	4	_aAntigen Presentation _ximmunology
650	0	4	_aAntigens, Bacterial _xadministration & dosage
650	0	4	_aCell Wall _xchemistry
650	0	4	_aClonal Anergy _ximmunology
650	0	4	_aCulture Media, Conditioned _xchemistry
650	0	4	_aGlutaral _xpharmacology
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xanalysis
650	0	4	_aInterleukin-10 _xanalysis
650	0	4	_aInterleukin-2 _xanalysis
650	0	4	_aInterleukin-4 _xanalysis
650	0	4	_aLeprosy _ximmunology
650	0	4	_aLeukocytes, Mononuclear _ximmunology
650	0	4	_aLiposomes
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMycobacterium leprae _ximmunology
650	0	4	_aMycobacterium tuberculosis _ximmunology
650	0	4	_aPeptides _ximmunology
650	0	4	_aSodium Fluoride _xpharmacology
650	0	4	_aT-Lymphocytes _xdrug effects
700	1		_aKhanna, Neena
700	1		_aChattree, Vineeta
700	1		_aPal, P C
700	1		_aHaq, W
700	1		_aRao, D N
773	0		_tInternational immunopharmacology _gvol. 3 _gno. 12 _gp. 1589-600
856	4	0	_uhttps://doi.org/10.1016/S1567-5769(03)00181-4 _zAvailable from publisher's website
999			_c14298672 _d14298672